Trial Outcomes & Findings for Comparison of Two Silicone Hydrogel Multifocal Contact Lenses (NCT NCT04093258)
NCT ID: NCT04093258
Last Updated: 2021-12-01
Results Overview
Lens centration was assessed using a biomicroscope and was graded using the scale (Grade: 0, 1,2) with grade 0 represent Centered, Grade 1 = Slightly Decentered and Grade 2= substantially decentered. The data was then dichotomized into two groups: those with grade 1 or higher and those with grade 0 (centered). The percentage of participants with Grade 0 Lens centration was reported.
COMPLETED
NA
42 participants
6 to 8 days
2021-12-01
Participant Flow
In total, 42 subjects were enrolled in this study; of which, 41 were randomly assigned into 2 sequences while, 1 subject failed to meet all eligibility criteria. Of the total assigned subjects, 40 subjects completed the study while, 1 subject was discontinued from the study.
Participant milestones
| Measure |
Test/Control
Subjects randomized to this sequence received the Test lens during the first period and then received the Control lens during the second period.
|
Control/Test
Subjects randomized to this sequence received the Control lens during the first period and then received the Test lens during the second period.
|
|---|---|---|
|
Period 1
STARTED
|
21
|
20
|
|
Period 1
COMPLETED
|
21
|
20
|
|
Period 1
NOT COMPLETED
|
0
|
0
|
|
Period 2
STARTED
|
21
|
20
|
|
Period 2
COMPLETED
|
20
|
20
|
|
Period 2
NOT COMPLETED
|
1
|
0
|
Reasons for withdrawal
| Measure |
Test/Control
Subjects randomized to this sequence received the Test lens during the first period and then received the Control lens during the second period.
|
Control/Test
Subjects randomized to this sequence received the Control lens during the first period and then received the Test lens during the second period.
|
|---|---|---|
|
Period 2
Subject no longer meets the eligibility criteria
|
1
|
0
|
Baseline Characteristics
Comparison of Two Silicone Hydrogel Multifocal Contact Lenses
Baseline characteristics by cohort
| Measure |
All Subjects
n=41 Participants
All subjects dispensed a study lens.
|
|---|---|
|
Age, Continuous
|
51.2 Years
STANDARD_DEVIATION 6.76 • n=5 Participants
|
|
Sex: Female, Male
Female
|
32 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
9 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
39 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
USA
|
41 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 6 to 8 daysPopulation: All subjects dispensed at least one study lens.
Lens centration was assessed using a biomicroscope and was graded using the scale (Grade: 0, 1,2) with grade 0 represent Centered, Grade 1 = Slightly Decentered and Grade 2= substantially decentered. The data was then dichotomized into two groups: those with grade 1 or higher and those with grade 0 (centered). The percentage of participants with Grade 0 Lens centration was reported.
Outcome measures
| Measure |
Test
n=41 Participants
Subjects that wore the Test lens in either the first or second period of the study.
|
Control
n=41 Participants
Subjects that wore the Control lens in either the first or second period of the study.
|
|---|---|---|
|
Percentage of Participants With Lens Centration
|
97.3 Percentage of participants
|
91.9 Percentage of participants
|
PRIMARY outcome
Timeframe: 6 to 8 daysPopulation: All subjects dispensed at least one study lens.
Lens movement in primary gaze was assessed using a biomicroscope and was graded using the scale (Insufficient/Unacceptable (-2), Minimal/Acceptable (-1), Optimal (0), Moderate/Acceptable (+1) and Excessive/Unacceptable (+2)) with Optimal (0) representing no lens movement. The data was then dichotomized into two groups: those with Optimal Lens movement and otherwise (-2, -1, +1 and +2). The percentage of participants with Optimal Lens movement was reported.
Outcome measures
| Measure |
Test
n=41 Participants
Subjects that wore the Test lens in either the first or second period of the study.
|
Control
n=41 Participants
Subjects that wore the Control lens in either the first or second period of the study.
|
|---|---|---|
|
Percentage of Participants With Lens Movement
|
97.3 Percentage of participants
|
91.9 Percentage of participants
|
SECONDARY outcome
Timeframe: 6 to 8 daysPopulation: All subjects who had successfully completed all visits and did not substantially deviate from the protocol as determined by the trial cohort review committee prior to database hard lock. Here 'N' (number of participants analyzed) included all participants who were evaluable for this outcome measure.
Overall handling was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, aged 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.
Outcome measures
| Measure |
Test
n=37 Participants
Subjects that wore the Test lens in either the first or second period of the study.
|
Control
n=37 Participants
Subjects that wore the Control lens in either the first or second period of the study.
|
|---|---|---|
|
Overall Handling Scores
|
60.3 CLUE points
Standard Deviation 19.02
|
55.3 CLUE points
Standard Deviation 18.71
|
Adverse Events
Test
Control
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Thomas R. Karkkainen, OD, MS, FAAO
Johnson & Johnson Vision Care
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: GT60